NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

You can opt out at anytime by visiting our cookie policy page. In line with the provisions of the GDPR, the provision of your personal data is a requirement necessary to enter into a contract. We must advise you at the point of collecting your personal data that it is a required field, and the consequences of not providing the personal data is that we cannot provide this service to you.


[profilepress-login id="1"]

Don't have an account? Subscribe

ADVERTISEMENT

ADVERTISEMENT

Funding issues over the transfer of penile cancer service

By Dermot - 21st Jan 2020

The need for funding to facilitate the transfer of the penile cancer service to Beaumont Hospital, Dublin, was highlighted at a recent meeting of the National Cancer Control Programme’s (NCCP) executive management team. The national penile cancer service is currently based in University Hospital Waterford (UHW).

“NCCP agrees in principle with the move, but funding will be required,” according to minutes of the 7 October meeting, seen by the Medical Independent (MI) through Freedom of Information law. It was proposed that the CEO of the RCSI Hospitals Group and the CEO of the South/South West Hospital Group meet to discuss replacement funding for Waterford.

There are approximately 25 penile cancer patients a year, requiring a range of services, including sentinel node mapping and nuclear medicine. A spokesperson for the HSE told MI patients travel from all over Ireland to the UHW service.

“This is particularly challenging for those travelling from the north-west of the country,” according to the spokesperson.

“There is a clinical consensus that this is suboptimal for patients.”

They added that the move to Beaumont is “only at the planning stage and is dependent on multiple factors, including funding and investment”.

It is hoped the move can take place by the end of 2020.

ADVERTISEMENT

Latest

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT